KAPRUKA

#GRTX New Target : USD 12.04 -13.07-17.05 @ 31%-60% -105%

Long
NASDAQ:GRTX   Galera Therapeutics, Inc.
New Target : USD 12.04-13.07-17.05

Resistance 4 : USD 12.04
Resistance 3 : USD 10.83
Resistance 2 : USD 10.03
Resistance 1 : USD 09.33

Support 1 : USD 07.28
Support 2 : USD 05.88


Sector: Health Technology
Industry: Pharmaceuticals: Major


Galera Therapeutics, Inc. operates as a clinical-stage biotechnology company. It focuses on developing and commercializing a pipeline of novel, proprietary therapeutics for cancer. The firm involves in the prevention of radiation-induced toxicity, including mucositis and the treatment of fibrosis and cancer. Its product candidate GC4419 reduces severe oral mucositis in patients with head and neck cancer undergoing radiation therapy and also receiving cisplatin, a chemotherapy drug. The company was founded by Robert A. Beardsley, Randy W. Weiss, and Dennis P. Riley in 2009 and is headquartered in Malvern, PA.

**Disclaimer - This is not a financial advice, please trade with caution and on your own risk. This prediction Based on My Dreams.
Do not view this idea as a recommendation for trading or investing. Risk Only What You Can Afford. Always Use a Stop Loss. Past performance is not necessarily a guide to future performance.

I would appreciate your feedback on my analysis.

Cheers
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.